Chemical synthesis API manufacturing technology Analytics of APIs and drug forms Drug form technology Bioavailability and bioequivalence studies Patent survey Registration


  OFFER > BIOAVAILABILITY AND BIOEQUIVALENCE STUDIES

Statement of GLP Compliance

The pharmacokinetic studies, including bioavailability and bioequivalence, are performed in the Pharmacology Department. Our services are in full compliance with OECD GLP (Statement of GLP Compliance No. 2/2010/GLP issued by Bureau for Chemical Substances and Preparations). We have performed over 60 studies for domestic and foreign pharmaceutical companies.

0.1 MB List of bioequivalence and bioavailability studies



Our services include:

  1. Literature studies and development of a study plan.
  2. Development or adaptation of bioanalytical methods for the determination of active substance and/or metabolites in biological fluids.
  3. Bioanalytical method validation according to EMEA and FDA.
  4. Determination of active substance and/or metabolites concentration in biological fluids (HPLC, LC/MS/MS).
  5. Pharmacokinetic parameters calculation (WinNonLin).
  6. Statistical analysis (SAS System for Windows).
  7. Study documentation in CTD Module 5 format:
    • 5.3.1.2. Comparative and Bioequivalence Study Reports
    • 5.3.1.4. Reports of Bioanalytical and Analytical Methods for Human Studies
Sample preparation Sample preparation Mass Spectrometer LCMS-2010 Mass Spectrometer LCMS-2010

GCP compliant partner research organizations:

  • Lambda Therapeutic Research
http://www.clinicalresearch.pl
  • Trial s.c. - Osrodek Badan Klinicznych
http://www.trial.pl
  • CRO Poland Sp. z o.o.
http://www.cro.com.pl
  • MTZ Clinical Research Sp. z o.o.
http://www.mtz-clinical.pl

 Head:  Piotr Rudzki, Ph.D.
 Phone:  (+48 22) 456 38 49
 Mobile:  (+48) 601 585 453
 Fax:  (+48 22) 456 38 38
 E-mail: